PAI
SLXP

Palo Alto Investors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Palo Alto Investors’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,300
Closed -$916K – 48
2015
Q1 		$916K Sell
5,300
-71,400
-93% -$10.5M 0.05% 42
2014
Q4 		$8.82M Buy
+76,700
New +$9.29M 0.52% 34

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Palo Alto Investors's SLXP Position: Q2 2015 in Review

Palo Alto Investors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 5,300 shares — an estimated $916K sold.

Palo Alto Investors first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $8.82M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Palo Alto Investors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Palo Alto Investors sold 5,300 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $916K.
  • Palo Alto Investors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • Palo Alto Investors's SALIX PHARMACEUTICALS LTD DEL position peaked at $8.82M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Palo Alto Investors's 13F filing for Q2 2015, filed 14 Aug 2015.